Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2026-02-20 @ 10:08 PM
Study NCT ID:
NCT02937168
Status:
TERMINATED
Last Update Posted:
2021-11-09
First Post:
2016-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-14
First Submit QC Date:
None
Study First Post Date:
2016-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-12
Results First Submit QC Date:
None
Results First Post Date:
2019-08-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-05
Last Update Post Date:
2021-11-09
Last Update Post Date Type:
ACTUAL